Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 4 |
2021 | 4 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Ex-vivo CS1-OKT3 dual specific bivalent antibody-armed effector T cells mediate cellular immunity against multiple myeloma.
Sci Rep. 2023 Nov 27;13(1):20853. doi: 10.1038/s41598-023-47115-7.
Sci Rep. 2023.
PMID: 38012196
Free PMC article.
Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma.
Awuah D, Minnix M, Caserta E, Tandoh T, Adhikarla V, Poku E, Rockne R, Pichiorri F, Shively JE, Wang X.
Awuah D, et al.
Cancer Immunol Immunother. 2023 Aug;72(8):2841-2849. doi: 10.1007/s00262-023-03461-z. Epub 2023 May 20.
Cancer Immunol Immunother. 2023.
PMID: 37209218
Free PMC article.
Item in Clipboard
A Mathematical Modeling Approach for Targeted Radionuclide and Chimeric Antigen Receptor T Cell Combination Therapy.
Adhikarla V, Awuah D, Brummer AB, Caserta E, Krishnan A, Pichiorri F, Minnix M, Shively JE, Wong JYC, Wang X, Rockne RC.
Adhikarla V, et al.
Cancers (Basel). 2021 Oct 15;13(20):5171. doi: 10.3390/cancers13205171.
Cancers (Basel). 2021.
PMID: 34680320
Free PMC article.
Item in Clipboard
Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model.
Minnix M, Adhikarla V, Caserta E, Poku E, Rockne R, Shively JE, Pichiorri F.
Minnix M, et al.
J Nucl Med. 2021 Jun 1;62(6):795-801. doi: 10.2967/jnumed.120.251983. Epub 2020 Oct 30.
J Nucl Med. 2021.
PMID: 33127621
Free PMC article.
Item in Clipboard
Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64-labeled daratumumab.
Krishnan A, Adhikarla V, Poku EK, Palmer J, Chaudhry A, Biglang-Awa VE, Bowles N, Nathwani N, Rosenzweig M, Sahebi F, Karanes C, Simpson J, Sanchez JF, Yamauchi D, Parayno M, Chowdhury A, Caserta E, Marcucci G, Rockne R, Wu AM, Wong J, Forman SJ, Colcher D, Yazaki P, Shively J, Pichiorri F.
Krishnan A, et al.
Blood Adv. 2020 Oct 27;4(20):5194-5202. doi: 10.1182/bloodadvances.2020002603.
Blood Adv. 2020.
PMID: 33095874
Free PMC article.
Clinical Trial.
Item in Clipboard
TAG-72-Targeted α-Radionuclide Therapy of Ovarian Cancer Using 225Ac-Labeled DOTAylated-huCC49 Antibody.
Minnix M, Li L, Yazaki PJ, Miller AD, Chea J, Poku E, Liu A, Wong JYC, Rockne RC, Colcher D, Shively JE.
Minnix M, et al.
J Nucl Med. 2021 Jan;62(1):55-61. doi: 10.2967/jnumed.120.243394. Epub 2020 Jul 3.
J Nucl Med. 2021.
PMID: 32620701
Free PMC article.
Item in Clipboard
Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting.
Viola D, Dona A, Caserta E, Troadec E, Besi F, McDonald T, Ghoda L, Gunes EG, Sanchez JF, Khalife J, Martella M, Karanes C, Htut M, Wang X, Rosenzweig M, Chowdhury A, Sborov D, Miles RR, Yazaki PJ, Ebner T, Hofmeister CC, Forman SJ, Rosen ST, Marcucci G, Shively J, Keats JJ, Krishnan A, Pichiorri F.
Viola D, et al.
Leukemia. 2021 Jan;35(1):189-200. doi: 10.1038/s41375-020-0810-4. Epub 2020 Apr 16.
Leukemia. 2021.
PMID: 32296125
Free PMC article.
Item in Clipboard
Cite
Cite